Literature DB >> 26139535

Myc or no Myc, that is the question.

Chun Chou1, Takeshi Egawa1.   

Abstract

The transcription factor c-MYC functions as the master transcription factor for establishing highly active metabolic states in proliferating cells. c-Myc is essential for rapid proliferation of normal cells and has causal relationship with many cancers, including leukemia and lymphoma. While the expression of c-MYC can be aberrantly driven by genetic abnormalities, such as chromosomal translocations directly involving the MYC locus or mutations of its upstream regulators, how c-MYC expression is induced and amplified in normal lymphocytes in response to antigen stimulation remains elusive. In this issue of The EMBO Journal, Preston et al (2015) report how c-MYC is selectively induced and amplified in the antigen‐specific T cells that undergo massive clonal expansion for host protection against pathogen infection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26139535      PMCID: PMC4551347          DOI: 10.15252/embj.201592267

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  13 in total

1.  c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.

Authors:  M A Gregory; S R Hann
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  IL-2 is not required for the initiation of CD8 T cell cycling but sustains expansion.

Authors:  Warren N D'Souza; Leo Lefrançois
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

3.  c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells.

Authors:  Zuqin Nie; Gangqing Hu; Gang Wei; Kairong Cui; Arito Yamane; Wolfgang Resch; Ruoning Wang; Douglas R Green; Lino Tessarollo; Rafael Casellas; Keji Zhao; David Levens
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

Review 4.  Metabolism in T cell activation and differentiation.

Authors:  Erika L Pearce
Journal:  Curr Opin Immunol       Date:  2010-02-26       Impact factor: 7.486

5.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

Review 6.  Metabolic reprogramming and metabolic dependency in T cells.

Authors:  Ruoning Wang; Douglas R Green
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

Review 7.  Transcriptional control of effector and memory CD8+ T cell differentiation.

Authors:  Susan M Kaech; Weiguo Cui
Journal:  Nat Rev Immunol       Date:  2012-10-19       Impact factor: 53.106

8.  Single cell tuning of Myc expression by antigen receptor signal strength and interleukin-2 in T lymphocytes.

Authors:  Gavin C Preston; Linda V Sinclair; Aneesa Kaskar; Jens L Hukelmann; Maria N Navarro; Isabel Ferrero; H Robson MacDonald; Victoria H Cowling; Doreen A Cantrell
Journal:  EMBO J       Date:  2015-07-01       Impact factor: 11.598

9.  Complete but curtailed T-cell response to very low-affinity antigen.

Authors:  Dietmar Zehn; Sarah Y Lee; Michael J Bevan
Journal:  Nature       Date:  2009-01-28       Impact factor: 49.962

10.  Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation.

Authors:  Linda V Sinclair; Julia Rolf; Elizabeth Emslie; Yun-Bo Shi; Peter M Taylor; Doreen A Cantrell
Journal:  Nat Immunol       Date:  2013-03-24       Impact factor: 25.606

View more
  3 in total

1.  Urate crystals directly activate the T-cell receptor complex and induce T-cell proliferation.

Authors:  Theodoros Eleftheriadis; Georgios Pissas; Maria Sounidaki; Georgia Antoniadi; Ioannis Tsialtas; Vassilios Liakopoulos; Ioannis Stefanidis
Journal:  Biomed Rep       Date:  2017-08-04

2.  CD28-ζ CAR T Cells Resist TGF-β Repression through IL-2 Signaling, Which Can Be Mimicked by an Engineered IL-7 Autocrine Loop.

Authors:  Viktória Golumba-Nagy; Johannes Kuehle; Andreas A Hombach; Hinrich Abken
Journal:  Mol Ther       Date:  2018-07-10       Impact factor: 11.454

3.  BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways.

Authors:  Yang Zhang; Bingwei Xu; Junfeng Shi; Jieming Li; Xinlan Lu; Li Xu; Helen Yang; Nevean Hamad; Chi Wang; Dana Napier; Shuixiang He; Chunming Liu; Zeyi Liu; Hai Qian; Li Chen; Xiaowei Wei; Xucai Zheng; Jian-An Huang; Olivier Thibault; Rolf Craven; Dongping Wei; Yueyin Pan; Binhua P Zhou; Yadi Wu; Xiuwei H Yang
Journal:  Cell Oncol (Dordr)       Date:  2020-10-02       Impact factor: 6.730

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.